Sanofi Consumer Healthcare India Ltd
₹ 4,818
-0.29%
14 Nov
- close price
About
[
edit about
]
[
add key points
]
- Market Cap ₹ 11,097 Cr.
- Current Price ₹ 4,818
- High / Low ₹ 5,499 / 4,212
- Stock P/E
- Book Value ₹ 80.2
- Dividend Yield 0.00 %
- ROCE %
- ROE %
- Face Value ₹ 10.0
Pros
Cons
- Stock is trading at 60.1 times its book value
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Multinational
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Operating Profit |
OPM % |
Interest |
Depreciation |
Profit before tax |
Tax % |
EPS in Rs |
Dividend Payout % |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | % |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | % |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | % |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | % |
Balance Sheet
Figures in Rs. Crores
Equity Capital |
Reserves |
Total Liabilities |
CWIP |
Investments |
Total Assets |
Cash Flows
Figures in Rs. Crores
Net Cash Flow |
Ratios
Figures in Rs. Crores
Debtor Days |
Inventory Days |
Days Payable |
Cash Conversion Cycle |
Working Capital Days |
ROCE % |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
13 Nov - Copies of the Postal Ballot Notice of the Company published on 13th November 2024, in Business Standard and Sakal newspapers.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
13 Nov - Copies of the Newspaper publication of Financial Results for Quarter and Nine months ended 30th September 2024, of the Company published on 13th November 2024, …
-
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
12 Nov - Postal ballot for appointing directors and related party transactions.
-
Unaudited Financial Results For The Quarter And Nine Months Ended 30Th September 2024
12 Nov - Approved unaudited financial results for Q3 2024.
-
Board Meeting Outcome for Board Meeting Outcome For The Unaudited Financial Results For The Quarter And Nine Months Ended 30Th September 2024
12 Nov - Approved unaudited financial results for Q3 2024.
Annual reports
No data available.